Represented Physician’s Choice, a probiotic and plant-based supplements company, in its withdrawn sale of the company transactionįood and Beverage and other Consumer Products :.Represented Locus Fermentation Solutions, a leading developer of customized biosurfactant solutions that are used by its clients to achieve sustainability and ESG goals, in various corporate matters.Represented Physicians Exclusive (also known as Microbiome Labs), a probiotic bacteriotherapy company with a comprehensive portfolio of proprietary probiotic and microbiome solutions for the consumer health industry, in its sale of the company transaction to Novozymes A/S, a Denmark-based biotechnology company.Represented Geneden Biotech, a probiotics company and the developer of BC30, a lactic acid producing bacteria that has been used as an ingredient in functional foods, dietary supplements, and medical foods, in the sale of the company transaction to Kerry Group.Represented Microbe Formulas, a wellness platform that provides dietary supplements and other natural solutions for gut health, in a sale of the company transaction with a private equity investor.Experienceīiotech/Vitamins, Supplements and Minerals : Ariel served for several years as the practice group leader of the firm’s corporate and securities practice group. Ariel has completed transactions in a wide range of industries in which he developed an extensive knowledge base and experience, such as biotechnology and vitamins, supplements and minerals, food and beverage, and technology.Īriel is also Team Leader of the firm’s Israel Practice and has extensive experience with legal and business issues involving Israel.
Ariel’s private equity practice also includes advising private equity funds in the management of their portfolio companies, including in connection with add-on acquisitions, equity and debt financing, dividend recapitalization, reorganization, and corporate governance.Īriel is a trusted hands-on adviser to his private equity and corporate clients. Ariel’s practice is primarily focused on representing private equity funds and private and public companies in domestic and cross border business transactions, including mergers and acquisitions, leveraged buyouts, growth equity, minority investments, financing, restructuring, joint ventures, and general corporate matters. Ariel Yehezkel is a transactional partner in the firm's New York office.
0 kommentar(er)
